How do comorbidities affect prognosis in anxiety disorders?

How do comorbidities affect prognosis in anxiety disorders?

• A. Higher risk, greater impairment, and more complex treatment; comorbidity with mood disorders or other anxiety disorders worsens prognosis.
• B. Comorbidity improves prognosis
• C. Has no effect
• D. Only affects treatment cost

Answer: (A)

Comorbidity increases the overall illness burden in anxiety disorders, so prognosis tends to be worse when another condition is present. When anxiety occurs alongside a mood disorder or another anxiety disorder, symptoms often amplify each other, leading to greater distress and functional impairment (work, relationships, daily functioning) and a longer, more complex treatment course. This means treatment has to address multiple conditions, which can slow recovery, raise the chance of relapse, and require longer or more intensive care. In short, comorbidity makes symptoms harder to control and functioning harder to restore, not easier. The idea that comorbidity would improve prognosis or have no effect contradicts the observed pattern that added conditions typically worsen outcomes. While comorbidity can add to treatment costs, the main prognostic impact is the greater symptom burden and impairment, not cost alone.

Comorbidity increases the overall illness burden in anxiety disorders, so prognosis tends to be worse when another condition is present. When anxiety occurs alongside a mood disorder or another anxiety disorder, symptoms often amplify each other, leading to greater distress and functional impairment (work, relationships, daily functioning) and a longer, more complex treatment course. This means treatment has to address multiple conditions, which can slow recovery, raise the chance of relapse, and require longer or more intensive care. In short, comorbidity makes symptoms harder to control and functioning harder to restore, not easier.

The idea that comorbidity would improve prognosis or have no effect contradicts the observed pattern that added conditions typically worsen outcomes. While comorbidity can add to treatment costs, the main prognostic impact is the greater symptom burden and impairment, not cost alone.